Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes (Q37437155)
Jump to navigation
Jump to search
scientific article published on 14 September 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes |
scientific article published on 14 September 2009 |
Statements
1 reference
Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes (English)
1 reference
Masahiro Yamamoto
1 reference
Toru Yamaguchi
1 reference
Mika Yamauchi
1 reference
Toshitsugu Sugimoto
1 reference
14 September 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference